ALKACEL 5MG TABLET

ALKACEL 5mg Tablet is a prescription anticancer product containing melphalan, an alkylating agent widely used in the treatment of multiple myeloma and ovarian cancer. This targeted therapy helps control the growth of cancer cells by interfering with their DNA, supporting effective chemotherapy management under an oncologist’s supervision.

The active ingredient, melphalan, works by damaging the DNA of rapidly dividing cancer cells, preventing their replication and slowing disease progression. ALKACEL is commonly prescribed as part of a combination chemotherapy regimen to enhance treatment outcomes in patients with advanced cancers.

ALKACEL 5 mg Tablet is administered orally under strict oncologist guidance. This prescription-only product ensures consistent potency, safety, and therapeutic effectiveness, making it a reliable option for long-term cancer management in carefully monitored clinical settings.

Product Features

• Potent anticancer chemotherapy tablet
• Contains Melphalan 5 mg
• Used in multiple myeloma and ovarian cancer
• Alkylating agent chemotherapy drug
• Oral tablet dosage form
• Suitable for hospital and specialty oncology use
• Manufactured under strict pharmaceutical quality standards
• Prescription-required oncology medicine

How It Helps

• Damages DNA of cancer cells to prevent growth and multiplication
• Helps slow disease progression in multiple myeloma and ovarian cancer
• Supports effective chemotherapy when used in combination regimens
• Provides targeted anticancer therapy under an oncologist’s supervision